Lantern Pharma Inc. (LTRN) › Weighted Average Diluted SharesLantern Pharma Inc. (LTRN) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2022-12-31: 10.85M2023-12-31: 10.84M2024-12-31: 10.76M2025-12-31: 10.90M10.90M2022-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-3110.90M+1.3%2026-03-30From 2025-01-012024-12-3110.76M-0.7%2026-03-30From 2024-01-012023-12-3110.84M-0.1%2025-03-27From 2023-01-012022-12-3110.85M—2024-03-18From 2022-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)